Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

PROPEL-2: Prophylactic Negative Pressure Wound Therapy in Laparotomy Wounds

NCT: NCT05977816 · ACTIVE_NOT_RECRUITING

NCT IDNCT05977816
StatusACTIVE_NOT_RECRUITING
Start Date2023-07-14
Completion2026-12
SponsorRoyal College of Surgeons, Ireland (OTHER)
First posted
Last updated

Brief Summary

Post-operative wound issues in abdominal surgery have a significant impact on patient outcomes. This study is taking place to investigate if Negative Pressure Wound Therapy (NPWT) dressings reduces Surgical Site Infections, post surgical complications and improves scar appearance compared to standard dressings.

Frequently Asked Questions

What is PROPEL-2: Prophylactic Negative Pressure Wound Therapy in Laparotomy Wounds?

PROPEL-2: Prophylactic Negative Pressure Wound Therapy in Laparotomy Wounds is a clinical trial registered under NCT05977816. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05977816?

The current status of NCT05977816 (PROPEL-2: Prophylactic Negative Pressure Wound Therapy in Laparotomy Wounds) is: ACTIVE_NOT_RECRUITING.

When did PROPEL-2: Prophylactic Negative Pressure Wound Therapy in Laparotomy Wounds start?

PROPEL-2: Prophylactic Negative Pressure Wound Therapy in Laparotomy Wounds started on 2023-07-14.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.